These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18690827)

  • 21. Molecular Dynamics Pinpoint the Global Fluorine Effect in Balanoid Binding to PKCε and PKA.
    Hardianto A; Liu F; Ranganathan S
    J Chem Inf Model; 2018 Feb; 58(2):511-519. PubMed ID: 29341608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total synthesis of (-)-balanol, all stereoisomers, their N-tosyl analogues, and fully protected ophiocordin: an easy route to hexahydroazepine cores from garner aldehydes.
    Srivastava AK; Panda G
    Chemistry; 2008; 14(15):4675-88. PubMed ID: 18399526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors.
    Gracias V; Ji Z; Akritopoulou-Zanze I; Abad-Zapatero C; Huth JR; Song D; Hajduk PJ; Johnson EF; Glaser KB; Marcotte PA; Pease L; Soni NB; Stewart KD; Davidsen SK; Michaelides MR; Djuric SW
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2691-5. PubMed ID: 18362070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors.
    Rao AU; Xiao D; Huang X; Zhou W; Fossetta J; Lundell D; Tian F; Trivedi P; Aslanian R; Palani A
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1068-72. PubMed ID: 22182499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular docking of balanol to dynamics snapshots of protein kinase A.
    Wong CF; Kua J; Zhang Y; Straatsma TP; McCammon JA
    Proteins; 2005 Dec; 61(4):850-8. PubMed ID: 16245317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusarium merismoides Corda NR 6356, the source of the protein kinase C inhibitor, azepinostatin. Taxonomy, yield improvement, fermentation and biological activity.
    Ohshima S; Yanagisawa M; Katoh A; Fujii T; Sano T; Matsukuma S; Furumai T; Fujiu M; Watanabe K; Yokose K
    J Antibiot (Tokyo); 1994 Jun; 47(6):639-47. PubMed ID: 8040068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uncoupling Catalytic and Binding Functions in the Cyclic AMP-Dependent Protein Kinase A.
    Kim J; Li G; Walters MA; Taylor SS; Veglia G
    Structure; 2016 Mar; 24(3):353-63. PubMed ID: 26833386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development.
    Goekjian PG; Jirousek MR
    Curr Med Chem; 1999 Sep; 6(9):877-903. PubMed ID: 10495357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
    Verkhivker GM
    Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase.
    Bagdanoff JT; Jain R; Han W; Zhu S; Madiera AM; Lee PS; Ma X; Poon D
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3788-92. PubMed ID: 26259804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based optimization of novel azepane derivatives as PKB inhibitors.
    Breitenlechner CB; Wegge T; Berillon L; Graul K; Marzenell K; Friebe WG; Thomas U; Schumacher R; Huber R; Engh RA; Masjost B
    J Med Chem; 2004 Mar; 47(6):1375-90. PubMed ID: 14998327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural features underlying selective inhibition of GSK3β by dibromocantharelline: implications for rational drug design.
    Zhang N; Zhong R; Yan H; Jiang Y
    Chem Biol Drug Des; 2011 Mar; 77(3):199-205. PubMed ID: 21244636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An asymmetric aminohydroxylation approach to the azepine core of (-)-balanol.
    Masse CE; Morgan AJ; Panek JS
    Org Lett; 2000 Aug; 2(17):2571-3. PubMed ID: 10990399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of hymenialdisine, analogues and their evaluation as kinase inhibitors.
    Nguyen TN; Tepe JJ
    Curr Med Chem; 2009; 16(24):3122-43. PubMed ID: 19689287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of the catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor.
    Grodsky N; Li Y; Bouzida D; Love R; Jensen J; Nodes B; Nonomiya J; Grant S
    Biochemistry; 2006 Nov; 45(47):13970-81. PubMed ID: 17115692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tricyclic azepine derivatives: pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors.
    Smith L; Piatnitski EL; Kiselyov AS; Ouyang X; Chen X; Burdzovic-Wizemann S; Xu Y; Pan W; Chen X; Wang Y; Rosler RL; Patel SN; Chiang HH; Milligan DL; Columbus J; Wong WC; Doody JF; Hadari YR
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1643-6. PubMed ID: 16412636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural origins of AGC protein kinase inhibitor selectivities: PKA as a drug discovery tool.
    Åberg E; Lund B; Pflug A; Gani OA; Rothweiler U; de Oliveira TM; Engh RA
    Biol Chem; 2012 Oct; 393(10):1121-9. PubMed ID: 23092797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel inhibitors of tropomyosin-related kinase A through the structure-based virtual screening with homology-modeled protein structure.
    Park H; Chi O; Kim J; Hong S
    J Chem Inf Model; 2011 Nov; 51(11):2986-93. PubMed ID: 22017333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.
    Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H
    J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model.
    Li S; Zhou Y; Lu W; Zhong Y; Song W; Liu K; Huang J; Zhao Z; Xu Y; Liu X; Li H
    J Chem Inf Model; 2011 Nov; 51(11):2939-47. PubMed ID: 21995341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.